Comprehensive review of GLP-1 molecular mechanisms: receptor binding, G protein/β-arrestin signaling, biased agonism, and downstream pathways mediating metabolic, cardiovascular, and neuroprotective effects.
Blueprint for better drugsComplete molecular mapping of GLP-1 signaling enables designing drugs that activate the right pathways (benefits) while avoiding others (side effects)
What the researchers found
Comprehensive GLP-1 molecular mechanisms: receptor binding, G protein/β-arrestin dual signaling, biased agonism, and downstream pathways mediating metabolic, cardiovascular, and neuroprotective therapeutic effects.
Why it matters
Understanding molecular mechanisms enables designing drugs that selectively activate beneficial pathways while avoiding those causing side effects.
How the study worked
Molecular biology review of GLP-1 receptor signaling pathways and therapeutic mechanisms.
What this study cannot tell us
Molecular mechanisms primarily from cell/animal studies. Human-specific differences possible.
How to read the evidence
Molecular mechanism review.
When this study was published
Published in 2025.
The bigger picture
Complete molecular understanding of GLP-1 enables rational design of next-generation biased agonists with optimized therapeutic profiles.
Questions still open
- Could biased GLP-1 agonists minimize GI side effects while maintaining CV protection?
- Which signaling pathway is most important for neuroprotection?
- Would receptor structure-guided design produce better drugs?
Common questions
How does GLP-1 work at the molecular level?
Could better molecular understanding lead to better drugs?
Read the original research
The Multifaceted Nature of GLP-1: Molecular Mechanisms and Signaling Pathways in Metabolic and Neurodegenerative Diseases.
International journal of molecular sciences, 27(4)
Citation
Kowalska, Małgorzata Katarzyna; El-Mallul, Ahmed; Hudecka, Weronika; Lubojańska, Joanna Elżbieta; Lubojański, Piotr Jan; Orłowska, Sara Małgorzata; Bednarczyk, Łukasz. (2026). The Multifaceted Nature of GLP-1: Molecular Mechanisms and Signaling Pathways in Metabolic and Neurodegenerative Diseases.. International journal of molecular sciences, 27(4). https://doi.org/10.3390/ijms27041886